Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ACADIA Pharmaceuticals (ACAD – Research Report) and Boston Scientific (BSX – Research Report). ACADIA Pharmaceuticals (ACAD) In a report released today, Ami Fadia from Needham maintained a Hold rating on ACADIA Pharmaceuticals. The company's shares closed last Wednesday at $19.29. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-pharmaceuticals-acad-and-boston-scientific-bsx?utm_source=advfn.com&utm_medium=referral
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Acadia Pharmaceuticals Charts.
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Acadia Pharmaceuticals Charts.